The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Is that a ramp ?!! Lol
Bring it on LOL
Apparently £10 per share !!!
There's a spelling error in the fifteenth line LOL
Link don’t work!
All will become clear by the end of this month, I hope and will be worth the wait. With the right marketing and key deliverables set out in viable timescales, it could be a very welcome addition to share portfolios.
Stemprinter Sciences Limited was incorporated on 3 September 2020. The aquisition of that company was made by Accustem Sciences Limited on 30 October 2020.
No shares have been issued to anyone yet and they cannot yet be traded.
Eligibility to receive them was back then, and was based on ownership of TILS shares (1 for 1).
Shares were issued in Oct 2020 , just took till now to get on companies house website.